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Technical aspects and current results of carotid
stenting
Alexandre d’Audiffret, MD, Pascal Desgranges, MD, Hicham Kobeiter, MD, and Jean-Pierre
Becquemin, MD, Créteil, France
Purpose: We reviewed our experience with carotid stenting (CS), focusing on technical evolution and results.
Methods: From September 1995 to February 2000, 77 patients with 83 internal (n = 68) and common carotid artery
lesions (n = 15) were selected for CS. This patient population was categorized into three consecutive periods based on
patient selection, material, and technical skills. For internal carotid artery lesions, period I included 11 patients treated
by means of direct carotid puncture with balloon expandable stents; period II included 42 patients treated by means
of a femoral approach with self-expandable stents; and period III included 15 patients in whom monorail system and
cerebral protection devices were used. Common carotid artery lesions were treated by means of carotid puncture in five
patients and by means of a femoral approach in 10 patients. In only two of the latter cases, cerebral protection devices
were used.
Results: The overall immediate success rate, defined as successfully treated stenosis with no neurological events, was
89.7% for internal carotid artery lesions and 100% for common carotid artery lesions. All neurological events, which
consisted of reversible events (4.4%), minor stroke (1.5%), and major stroke (2.9%), occurred during periods I and II.
In periods I, II, and III, the rate of surgical conversion was 18%, 9.5%, and 0%, respectively, the rate of transient
ischemic attack and reversible ischemic neurologic deficit was 0%, 7%, and 0%, respectively, and the rate of minor and
major stroke was 0%, 7%, and 0%, respectively. All major strokes were cleared with intra-arterial thrombolysis. At dis-
charge, the success rates defined by means of the absence of conversion and neurological events were 82% during period
I, 76% during period II, and 100% during period III. The freedom from neurological deficits rates were 100%, 97.6%,
and 100%, respectively. During follow-up, six significant asymptomatic restenoses were detected with duplex scanning;
however, only one patient required reintervention.
Conclusion: Technical skills and technological improvement, including low-profile balloon and catheter, cerebral pro-
tection device, and intra-arterial rescue techniques, may reduce the rate of neurological events associated with CS.
Technical improvements should be given careful consideration before the initiation of randomized trials comparing CS
and carotid endarterectomy. (J Vasc Surg 2001;33:1001-7.)
Recent randomized prospective trials have demon-
strated the safety and efficacy of carotid endarterectomy
(CEA) in preventing stroke in patients with severe steno-
sis.1-3 However, in a high-risk population, including
patients with lesions located at the base of the skull, hos-
tile necks caused by previous extensive surgery or radiation
therapy, and severe comorbidities, carotid angioplasty may
be an acceptable alternative to CEA. Noncontrolled
series have claimed the safety of this approach in selected
patients, with intermediate results comparable with con-
ventional surgery.4,5 However, this option may be haz-
ardous if used on a large scale. In a prospective
randomized trial, Naylor et al6 reported an unacceptable
rate of cerebrovascular complications in the angioplasty
group and terminated the trial prematurely. Currently,
two large prospective randomized trials are being
designed in France (EVA-3S) and the United States
(CREST) to compare carotid stenting and surgery.7,8
Because of rapid technological evolution, numerous
questions, including those about material, patient selec-
tion, and the interventionist’s training, remain unan-
swered. This led us to review our experience with carotid
stenting, highlighting the technical evolution of this pro-
cedure at our institution and presenting the immediate
and intermediate results since our first carotid angio-
plasty with a stent in 1995.
PATIENTS AND METHODS
Patient population
From September 1995 to February 2000, 77 of 531
patients scheduled for carotid surgery were selected for
carotid stenting. Stenoses were located in the internal
carotid artery (ICA) in 68 cases and in the common carotid
artery (CCA) in 15 cases. The average degree of stenosis
was 85% (range, 70%-95%). Thirty percent of the patients
with an ICA stenosis and 15% of patients with a CCA
stenosis had symptoms. Preoperative risk factors included
peripheral vascular disease (43%, n = 33), coronary artery
disease (40%, n = 30), diabetes mellitus (26%, n = 20),
hypertension (93%, n = 71), hypercholesterolemia (23%, n
= 18), and a history of smoking (85%, n = 65). The aver-
age patient age was 68.5 years (range, 44-88 years). All
patients underwent a color duplex scan of both carotid
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arteries, followed by an arteriogram of the aortic arch and
bilateral carotid arteries when the patient was being con-
sidered for a carotid angioplasty. Carotid repair was indi-
cated for symptomatic lesions 70% or larger and
asymptomatic lesions 80% or larger. Carotid angioplasty
was considered when the aortic arch was relatively healthy
and the common carotid had no or minimal angulation.
Also, heavily calcified, ulcerated carotid lesions and floating
thrombus were excluded. Fig 1 shows what we thought
was a good indication for carotid stenting, and Fig 2 shows
what we thought was a contraindication. The origins
included atherosclerosis (90%), restenosis after an earlier
endarterectomy (6%), and radiation-induced arteritis (4%).
All patients were informed of the experimental nature of
this procedure and signed an informed consent form.
Evolution of the technique
Because of our increased experience and the availability
of newer technologies (including guidewires, balloons,
stents, and cerebral protection devices), we retrospectively
divided this patient population into three periods. During
periods I and II, we limited carotid stenting to patients with
severe comorbidities or hostile necks caused by earlier radia-
tion therapy or surgery or restenosis after CEA. In contrast,
during period III, all patients with a favorable anatomy were
considered for carotid stenting. However, not all patients
were treated by means of angioplasty, mainly because of
cost-constraint regulation and the patient’s choice after an
explanation of the pros and the cons of the two techniques.
Patient distribution according to the three periods is sum-
marized in Table I. Eleven of 210 patients (5%) with ICA
stenoses were selected for angioplasty in period I, 42 (16%)
of 250 patients with ICA stenoses were selected for angio-
plasty in period II, and 15 (21%) of 71 patients with ICA
stenoses were selected for angioplasty in period III.
Endovascular procedures
The procedures were performed in an operating room
equipped with digital subtraction-capable fluoroscopic
Fig 1. A, Carotid angiogram shows atherosclerotic stenosis of the internal carotid artery. There is no tor-
tuosity or major circular calcification, and the plaque looks regular. This represents an acceptable indica-
tion for carotid stenting. B, Angiogram shows an excellent morphologic result (after stenting).
A B
Fig 2. Magnetic resonance angiography of carotid bifurcation
shows a tight stenosis and major tortuosity of both common and
distal internal carotid arteries. This case is a poor indication for
carotid stenting.
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equipment and standard monitoring techniques, including
intra-arterial pressure monitoring, oxymetry, and continu-
ous electrocardiography.
Period I. ICA stenoses were approached in patients
who were under general anesthesia via the CCA in 11
cases. We started the procedure with a road map
through a 18-gauge angiocatheter (Ethicon, S.p.A., Issy
les Moulineaux, France) and lodged the introducer wire
(Terumo, Leuven, Belgium) in the external carotid
artery. Then, a 6F short introducer sheath (Terumo) was
introduced with direct fluoroscopic guidance. The
lesion was crossed with a 0.035-in hydrophilic guidewire
(Terumo), and 50 U/kg heparin was given intra-
venously. In very tight stenoses, a predilation with a 3-
mm balloon was completed. A Palmaz stent (Cordis,
Roden, The Netherlands) mounted on a balloon dilata-
tion catheter was then deployed within the stenosis.
Stent dimensions were chosen to match the length of
the lesion and the diameter of the adjacent normal ICA.
After stent deployment, angiogram views included
anteposterior, oblique, and intracerebral views.
Period II. The procedure was performed under local
anesthesia through a femoral puncture, and 100 U/kg of
heparin was given intravenously. Through a 6F sheath
(Terumo), a vertebral catheter (Cordis) was advanced at
the level of the aortic arch and pushed into the CCA.
Then, a 0.035-in hydrophilic soft guidewire was advanced
into the external carotid artery and exchanged for a 0.035-
in stiff wire (Terumo). The introducer sheath was then
substituted with a 90-cm, 7F Arrow introducer (Arrow
Erding, Germany) that was advanced proximal to the
carotid bifurcation. Then, the carotid stenosis was crossed
with a 0.02-in hydrophilic guidewire (Terumo). We used
two types of self-expandable stents (Wallstent, Boston
Scientific, La Garenne Colombes, France; or Smart stent,
Cordis). After stent deployment, a balloon was inflated
within the stenosis to fully open the artery.
Period III. The main changes in this period were the
use of balloon cerebral protection devices (Percusurge,
Sunnyvale, Calif) and monorail self-expandable stents
(Carotid Wallstent; Boston Scientific). The stenoses were
crossed with the 0.014-in catheter, and the protection bal-
loon was inflated 1.5 to 2 cm distal to the stenosis.
Dilation and stent deployment proceeded with monorail
balloon (Guidant, Zaventern, Belgium) and stent delivery
devices. After stent deployment, plaque debris was
removed by means of the aspiration catheter.
Postoperative follow-up. Patients were given low
molecular weight heparin for 24 hours, followed by ticlo-
pidine or clopidogrel and aspirin for 4 weeks. All patients
underwent a carotid duplex scan before discharge and
then at 1 month, 6 months, 12 months, and yearly there-
after. When the duplex study was suspicious for a recurrent
stenosis, stent compression, or migration, we proceeded
to angiography.
Statistical analysis
Comparisons between groups and survival analysis were
performed with the SPSS software (SPSS, Chicago, Ill).
RESULTS
Eighty-three lesions were selected for carotid stenting.
In 79 cases (15 CCA lesions and 64 ICA lesions), the stent
was correctly deployed. No CCA lesion required conver-
sion to conventional surgery. Four patients with ICA
lesions underwent emergency CEA because of an inability
to cross the lesion (n = 3) or an inability to introduce the
sheath to the CCA (n = 1).
Procedural complications. Conversions and proce-
dural complications are presented in Fig 3. No ischemic
neurological events occurred during stent placement or
balloon dilation; however, the incidence of bradycardia
(pulse rate < 40 bpm) associated with hypotension (sys-
tolic blood pressure < 10 mm Hg) was 45.8% for ICA
lesions and 13.5% for CCA lesions. In most cases, cardiac
rhythm and blood pressure returned to reference range
values as soon as the balloon was deflated. Atropine was
given intravenously in only five cases. Two major strokes
occurred after stent deployment. In both cases, the loss of
a branch of the middle cerebral artery was shown by
means of an intraoperative angiogram with cerebral views.
These patients were given intracerebral urokinase infu-
sions (1 × 106 units). Both patients fully recovered and
had no residual neurological deficit. One patient sustained
a transient ischemic event that occurred 15 minutes after
stent deployment and resolved without sequelae 20 min-
utes later, and two more patients sustained an ischemic
neurological deficit with complete recovery in 12 hours.
No technical defects were revealed by means of a duplex
ultrasound scanning study.
Table I. Techniques for the periods of internal carotid angioplasty
Period I Period II Period III
No. of patients 11 42 15
Systemic anticoagulation 50 U/kg 100 U/kg sheath perfusion 100 U/kg sheath perfusion
Vascular access Direct common carotid artery Femoral artery Femoral artery
Size of guidewire (in) 0.035 0.020 0.014
Cerebral protection No No Yes
Type of stent Balloon expandable Self-expandable Monorail self-expandable
Indications Patients at high risk Patients at high risk All patients with 
favorable anatomy
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Among the three patients who required conversion to
CEA after stent deployment, one had a minor stroke that
was diagnosed during the period of recovery from general
anesthesia. This patient was converted to a formal CEA
after visualization of a thrombus within the stent. At dis-
charge, he had a minor sequelae. The two remaining con-
versions were necessary because of a more than 30%
residual stenosis and a severe kinking of the ICA distally to
the stent. As a result, the overall clinical success rate
(defined as successful stent deployment with no death,
residual stenosis, occlusion, or cerebral embolization) at
30 days was 82.3% (56 of 68) for ICA lesions and 100%
(15 of 15) for CCA lesions. The incidence of immediate
conversion because of stent complication was 4.6% (3 of
64). In addition, neurological events occurred in 9.3% (6
of 64) of all ICA cases in which a stent was deployed. Yet
only one patient sustained a permanent mild neurological
deficit (1.5%). Results for the period of angioplasty are
presented in Table II. For CCA stenting, the procedures
were uneventful.
Follow-up clinical events. The mean length of
follow-up in this study was 21 months (range, 1-60
months). One patient died at 6 months of esophageal car-
cinoma. Life-table analysis of survival free of symptoms
and recurrent stenosis for CCA and ICA stenting are
shown in Fig 4. The differences were not statistically sig-
nificant. No stent compression was detected; however,
intimal hyperplasia with a more than 50% stenosis was
detected by means of duplex examination and angiogra-
phy in three CCA stents and three ICA stents. One of
these patients required a carotid bypass grafting procedure
16 months after carotid stenting. One patient with
Takayasu disease sustained an occlusion, which was
revealed by one episode of transient ischemic attack (TIA),
at 6 months. One more patient with an ICA stent sus-
tained a single atypical neurological event classified as a
TIA. Protrusion of the stent within the carotid bulb,
which could have been a source of turbulence and ensuing
embolization, was revealed by means of a duplex study.
This patient continued to receive ticlopidine and aspirin
and had no recurrence of symptoms. The overall rate of
stenosis recurrence (> 50%) for ICA lesions was 4.9% (3 of
61) and 20% (3 of 15) for CCA lesions. A total of 98.4%
of patients were free of new neurological symptoms.
DISCUSSION
This review of our experience shows that, for the 68
ICA lesions scheduled for carotid stenting, immediate
Fig 3. Operative results after internal and common carotid stenting. CEA, Carotid endarterectomy; CVA,
cerebrovascular accident; RIND, reversible ischemic neurological deficit; TIA, transient ischemic attack.
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 5 d’Audiffret et al 1005
technical success was achieved in 94% (64 of 68) of the
cases. However, the incidence of embolic neurologic
events in this group was 9.3% (6 of 64), with a conversion
rate of 4.6% (3 of 64) caused by stent complications or
suboptimal results. Nevertheless, all deficits were tran-
sient, except for one lasting minor stroke that occurred
after a surgical conversion. In contrast, 15 CCA lesion
cases had an uneventful postoperative course.
A recent review of the world experience on carotid
stenting, which was obtained by means of a questionnaire
survey without quality controls, showed better results,
with an overall technical success rate of 98.6% and an asso-
ciated major and minor stroke rate of 1.32% and 3.08%,
respectively.5 However, Diethrich et al4 reported an over-
all success rate of 89% with a stroke rate of 6.4% and a TIA
rate of 4.5% in patients with symptoms. This latter report
emphasizes the relatively high rate of neurological compli-
cations associated with this procedure, as compared with
that of conventional surgery. Recent reviews have
attempted to present objective summaries of currently
available data.9,10 In a meta-analysis of 33 studies of
angioplasty and surgery, Golledge et al9 reported a 30-day
stroke and mortality rate of 7.1% after angioplasty and
3.3% after surgery. The fatal or disabling stroke rate was
3.2% and 1.6%, respectively, which led the authors to the
conclusion that for symptomatic carotid lesions angio-
plasty had worse results than surgery. From these reviews,
we cannot anticipate the impact of the new technology,
notably low profile and monorail catheter, systematic
stenting, and cerebral protection devices. Our data,
although limited and preliminary, seem to show some
advantages with these latest developments and the benefi-
cial effect of expertise. Our relatively acceptable results
were obtained in a selected group of patients, in whom
there was no major tortuosity and no major calcification of
the plaque. It remains unknown whether poorer results
would have been observed with expanded indications.
Randomized trials are being designed to determine
the efficacy of carotid stenting, as compared with that of
surgery. Consequently, a number of considerations,
including type of stent, vascular access, delivery system,
and cerebral protection, need to be discussed, because
they may directly affect the outcome of these trials.
Although the need to stent carotid lesions to prevent dis-
section, thrombosis, or early restenosis is well accepted,
the type of stent that may offer the best results has not
been clearly established. Early in our experience (period I),
balloon expandable stents were preferred for their radial
force and because once the stent was placed, no further
balloon manipulation was required. However, predilation,
with its potentially higher risk of cerebral embolization,
was frequently required, the rigidity of the stent was a lim-
iting factor in tortuous arteries, and reports of stent col-
lapse or crimping were worrisome.11
We then elected to change to self-expandable stents
(periods II and III), which have the benefit of great flexi-
bility, steerability, and low profile delivery systems. These
stents encompassed the bulk of our experience as the com-
plexity of the cases increased. In addition, self-expandable
stents can be easily deployed across the carotid bifurcation,
allowing for the lumen diameter discrepancy between the
ICA and CCA without compromising the patency of the
external carotid artery.
Several authors have reported acceptable results with
direct percutaneous carotid puncture, which was con-
firmed by our initial experience.4,12,13 This approach pre-
sents certain technical difficulties and potentially severe
complications, including cervical hematomas, thrombosis
Fig 4. Cumulative survival rate free of restenosis and neurological events in patients with common carotid
artery (CCA) or internal carotid artery (ICA) stenting.
of the angioplasty site because of the decreased flow dur-
ing the compression process, and patient discomfort. The
femoral approach remains the most acceptable approach,
despite the required skills and the risk of plaque emboliza-
tion from the aortic arch during selective catheterization.
However, the direct carotid approach should not be
excluded, because it may prove useful in patients with a
difficult aortic arch or tortuous CCA.
Another relevant change to carotid stenting was the
use of a cerebral protection device. Several authors have
underlined the risk of cerebral embolization.14-16 Jordan et
al17 have demonstrated by means of transcranial Doppler
monitoring that carotid stenting was associated with more
than eight times the rate of microemboli that was noted
during CEA. In our series, all neurological complications
occurred when no protection device was used. Salvage by
means of intracerebral urokinase infusion with micro-
catheter techniques led to full recovery in two of our
patients. Interventionalists starting carotid stenting should
be aware of and trained in these rescue techniques.
However, even with the favorable final outcome during
periods I and II, the results obtained during period III,
despite the small number of cases included, led us to
believe that cerebral protection may be a cornerstone in the
evolution of this procedure. There are different systems
based either on a balloon-tipped guidewire or a filter that
deploys like an umbrella. Ohki et al18 have demonstrated
in vitro that a filter cerebral protection device may capture
as much as 88% of embolic particles. The monorail system
used in the current series presents several advantages com-
pared with the axial systems, including speed, minimal
manipulation, and shorter guidewires. This is confirmed by
our average ICA occlusion time of 9 minutes, which com-
pares favorably with that of a formal CEA. Although the
clamping time may not be an issue for a safe procedure in
most CEAs, there is a subset of patients who do not toler-
ate the ICA clamping and who require either a quick repair
or, more safely, the placement of a shunt.19
Long-term results of carotid stenting, as compared
with those of CEA, are still unavailable. In the current
series, the combined survival rate free of neurological
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events and restenosis may eventually have been worse than
that after CEA. For carotid artery lesions, we have
reported a 7.9% restenosis rate for 21 months. Only one
patient required a surgical intervention for a stenosis larger
than 85%. The restenosis rate was 4.9% with ICA and 20%
with CCA. The reasons for this difference are unclear.
Two CCA restenoses (both CCAs were stented) occurred
in a single patient, and we speculated that there was a
rapidly evolving atherosclerosis. Another clue was the
length of the stents, but the figures were too small to draw
firm conclusions.
In conclusion, carotid stenting requires great expertise
in catheter manipulation. The current technical refine-
ments, including the use of a cerebral protection device,
are appealing. However, only randomized trials will
answer the question of what the best treatment option, as
compared with carotid surgery, is. However, we think that
it may be premature to initiate such trials before the wide
acceptance and development of the skills necessary for the
manipulation of cerebral protection devices and monorail
systems.
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